羊膜市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

羊膜市場は、2023年に10億2,000万米ドルと評価され、2024年には11億3,000万米ドルに達すると予測され、CAGR 9.26％で成長し、2030年には19億米ドルに達すると予測されています。

羊膜市場は、妊婦の胎盤組織に由来する生体組織の研究と供給に関わる。抗炎症性、抗線維化性、抗菌性で有名で、創傷治癒、眼科、再建手術に役立っています。羊膜市場の範囲は、医療用、特殊用、眼科用と多岐にわたり、病院、診療所、外来手術センター、専門治療センターなどのエンドユーザーにサービスを提供しています。この市場の重要な成長要因は、高度で効果的な治療オプションを必要とする慢性疾患や傷害の有病率の上昇であり、低侵襲手術に対する需要の高まりでもあります。医療技術の進歩も市場を強化し、製品の有効性の向上と新たな応用分野の可能性を提供しています。主なビジネスチャンスは、再生医療における用途の拡大や、新たな送達形式の探求にあります。しかし、この市場は、厳しい規制要件や、組織の採取と製造をめぐる潜在的な倫理問題などの制約に直面しています。さらに、羊膜製品は比較的高価であるため、特にコストに敏感な市場では、普及を妨げる可能性があります。ヘルスケア分野の規制が厳しくなるにつれて、企業は製品の費用対効果の改善、生体適合性の向上、膜の保存や適用方法の進歩といった分野でイノベーションを見出すことができます。合成または生物工学的な代替品の調査により、新たな成長の道が開けるかもしれないです。市場力学は競合情勢を示しており、企業は革新と差別化を迫られています。市場の性質は主に、急速な技術の進歩と個別化医療への継続的なシフトに影響されています。成長機会を効果的に活用するため、市場参入企業は戦略的提携を優先し、研究開発投資を徹底し、規制状況への働きかけを行い、承認プロセスを合理化することで、市場への浸透を強化し、進化する医療情勢の中でより強い存在感を確立する必要があります。

市場力学：急速に進化する羊膜市場の主要市場インサイトを公開

羊膜市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 羊膜移植の需要
  • 世界の老人人口の増加
  • 事故や外傷の発生率の増加
• 市場抑制要因
  • ヘルスケア分野における熟練した専門家の不足
• 市場機会
  • 羊膜における再生医療と幹細胞生物学の研究開発活動の増加
  • 羊膜の利点と出生組織提供に対する認知の高まり
• 市場の課題
  • 十分な保存温度レベルの維持

ポーターの5つの力：羊膜市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：羊膜市場における外部からの影響の把握

外部マクロ環境要因は、羊膜市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析羊膜市場における競合情勢の把握

羊膜市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス羊膜市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、羊膜市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品上市、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 羊膜移植の需要
    • 世界中で高齢者人口が増加
    • 事故や外傷の発生件数の増加
  • 抑制要因
    • ヘルスケア分野における熟練した専門家の不足
  • 機会
    • 再生医療・幹細胞生物学の羊膜における研究開発活動の拡大
    • 羊膜のメリットと出産組織の寄付に対する意識の高まり
  • 課題
    • 十分な保管温度レベルを維持する
• 市場セグメンテーション分析
  • 製品：凍結保存羊膜生細胞療法の利用増加
  • 応用：複雑な眼表面疾患を治療する眼科における羊膜の活用
  • エンドユーザー：病院全体で外科手術に頻繁に使用される製品
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 羊膜市場：製品別

• 冷凍保存された羊膜
• 凍結乾燥羊膜

第7章 羊膜市場：用途別

• 眼科
• 手術創

第8章 羊膜市場：エンドユーザー別

• 外来手術センター
• 病院
• 研究センター研究所
• 専門クリニック

第9章 南北アメリカの羊膜市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の羊膜市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの羊膜市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • NovaBay、羊膜組織同種移植をAvenova Allograftとして商品化へ
  • コロプラスト、ケレシス買収合意を発表、長期成長期待を引き上げ

企業一覧

• VIVEX Biologics, Inc.
• Stryker Corporation
• Smith & Nephew PLC
• Celularity Inc.
• Lucina BioSciences, LLC
• Thea Pharma Inc.
• Merakris Therapeutics
• Ventris Medical, LLC
• NuVision Biotherapies Ltd
• FzioMed Inc.
• Laboratoire CCD
• Surgenex, LLC
• Surgilogix
• BioTissue Holdings, Inc.
• Integra LifeSciences Holdings Corporation
• Katena Products, Inc.
• Genesis Biologics Inc.
• PuraGraft
• Seed Biotech, Inc.
• The Electrospinning Company
• MiMedx Group, Inc.
• Applied Biologics, LLC
• Skye Biologics Holdings, LLC
• BioStem Technologies, Inc.
• Organogenesis Holdings Inc.
• Next Biosciences（Pty）Limited

LIST OF FIGURES

• FIGURE 1. AMNIOTIC MEMBRANE MARKET RESEARCH PROCESS
• FIGURE 2. AMNIOTIC MEMBRANE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMNIOTIC MEMBRANE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. AMNIOTIC MEMBRANE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AMNIOTIC MEMBRANE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AMNIOTIC MEMBRANE MARKET DYNAMICS
• TABLE 7. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY CRYOPRESERVED AMNIOTIC MEMBRANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY LYOPHILIZATION AMNIOTIC MEMBRANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY SURGICAL WOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY RESEARCH CENTERS LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY SPECIALIZED CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. AMNIOTIC MEMBRANE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. AMNIOTIC MEMBRANE MARKET, FPNV POSITIONING MATRIX, 2023

The Amniotic Membrane Market was valued at USD 1.02 billion in 2023, expected to reach USD 1.13 billion in 2024, and is projected to grow at a CAGR of 9.26%, to USD 1.90 billion by 2030.

The amniotic membrane market involves the study and supply of a biological tissue derived from the placental tissue of pregnant women. It is renowned for its anti-inflammatory, anti-fibrotic, and anti-microbial properties, making it instrumental in wound healing, ophthalmology, and reconstructive surgeries. The scope of the amniotic membrane market extends across medical, specialty, and ophthalmic applications, serving an array of end-users including hospitals, clinics, ambulatory surgical centers, and specialized treatment centers. A significant growth driver for this market is the rising prevalence of chronic diseases and injuries that necessitate advanced and effective treatment options, paired with the growing demand for minimally invasive surgeries. Advances in medical technology also bolster the market, offering potential for enhanced product effectiveness and new application areas. Key opportunities lie in expanding applications within regenerative medicine and exploring novel delivery formats. However, the market faces limitations such as stringent regulatory requirements and potential ethical issues surrounding tissue harvesting and manufacturing. Additionally, the relatively high cost of amniotic membrane products can deter widespread adoption, especially in cost-sensitive markets. As regulations in the healthcare sector become more stringent, companies can find innovation in areas such as improving cost-effectiveness of products, enhancing bio-compatibility, and advancing the methods of membrane preservation and application. Research into synthetic or bioengineered alternatives may present new growth avenues. Market dynamics indicate a competitive landscape, with firms pressured to innovate and differentiate. The market's nature is primarily influenced by rapid technological advancements and an ongoing shift towards personalized medicine. To effectively capitalize on growth opportunities, market players should prioritize strategic collaborations, pursue rigorous R&D investments, and engage in regulatory advocacy to streamline approval processes, thereby enhancing market penetration and establishing a stronger presence in the evolving medical landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Amniotic Membrane Market

The Amniotic Membrane Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Demand for amniotic membrane transplantations
  • Rising the geriatric population around the world
  • Growing incidence of accident and trauma cases
• Market Restraints
  • Lack of skilled professionals in healthcare sector
• Market Opportunities
  • Increasing R&D activities in the amniotic membrane for regenerative medicine and stem cell biology
  • Growing awareness of amniotic membrane benefits and birth tissue donations
• Market Challenges
  • Maintaining sufficient storage temperature level

Porter's Five Forces: A Strategic Tool for Navigating the Amniotic Membrane Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Amniotic Membrane Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Amniotic Membrane Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Amniotic Membrane Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Amniotic Membrane Market

A detailed market share analysis in the Amniotic Membrane Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Amniotic Membrane Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Amniotic Membrane Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Amniotic Membrane Market, highlighting leading vendors and their innovative profiles. These include VIVEX Biologics, Inc., Stryker Corporation, Smith & Nephew PLC, Celularity Inc., Lucina BioSciences, LLC, Thea Pharma Inc., Merakris Therapeutics, Ventris Medical, LLC, NuVision Biotherapies Ltd, FzioMed Inc., Laboratoire CCD, Surgenex, LLC, Surgilogix, BioTissue Holdings, Inc., Integra LifeSciences Holdings Corporation, Katena Products, Inc., Genesis Biologics Inc., PuraGraft, Seed Biotech, Inc., The Electrospinning Company, MiMedx Group, Inc., Applied Biologics, LLC, Skye Biologics Holdings, LLC, BioStem Technologies, Inc., Organogenesis Holdings Inc., and Next Biosciences (Pty) Limited.

Market Segmentation & Coverage

This research report categorizes the Amniotic Membrane Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cryopreserved Amniotic Membrane and Lyophilization Amniotic Membrane.
• Based on Application, market is studied across Ophthalmology and Surgical Wound.
• Based on End User, market is studied across Ambulatory Surgical Center, Hospital, Research Centers Laboratory, and Specialized Clinic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Demand for amniotic membrane transplantations
    • 5.1.1.2. Rising the geriatric population around the world
    • 5.1.1.3. Growing incidence of accident and trauma cases
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled professionals in healthcare sector
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D activities in the amniotic membrane for regenerative medicine and stem cell biology
    • 5.1.3.2. Growing awareness of amniotic membrane benefits and birth tissue donations
  • 5.1.4. Challenges
    • 5.1.4.1. Maintaining sufficient storage temperature level
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increase in use of cryopreserved amniotic membranes live cell therapy
  • 5.2.2. Application: Employment of amniotic membrane in ophthalmology treating complex ocular surface diseases
  • 5.2.3. End User: Significant use products across Hospitals for surgical procedures
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Amniotic Membrane Market, by Product

• 6.1. Introduction
• 6.2. Cryopreserved Amniotic Membrane
• 6.3. Lyophilization Amniotic Membrane

7. Amniotic Membrane Market, by Application

• 7.1. Introduction
• 7.2. Ophthalmology
• 7.3. Surgical Wound

8. Amniotic Membrane Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Center
• 8.3. Hospital
• 8.4. Research Centers Laboratory
• 8.5. Specialized Clinic

9. Americas Amniotic Membrane Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Amniotic Membrane Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Amniotic Membrane Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. NovaBay to commercialize Amniotic Tissue Allograft as Avenova Allograft
  • 12.3.2. Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

Companies Mentioned

• 1. VIVEX Biologics, Inc.
• 2. Stryker Corporation
• 3. Smith & Nephew PLC
• 4. Celularity Inc.
• 5. Lucina BioSciences, LLC
• 6. Thea Pharma Inc.
• 7. Merakris Therapeutics
• 8. Ventris Medical, LLC
• 9. NuVision Biotherapies Ltd
• 10. FzioMed Inc.
• 11. Laboratoire CCD
• 12. Surgenex, LLC
• 13. Surgilogix
• 14. BioTissue Holdings, Inc.
• 15. Integra LifeSciences Holdings Corporation
• 16. Katena Products, Inc.
• 17. Genesis Biologics Inc.
• 18. PuraGraft
• 19. Seed Biotech, Inc.
• 20. The Electrospinning Company
• 21. MiMedx Group, Inc.
• 22. Applied Biologics, LLC
• 23. Skye Biologics Holdings, LLC
• 24. BioStem Technologies, Inc.
• 25. Organogenesis Holdings Inc.
• 26. Next Biosciences (Pty) Limited